• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    2/14/23 7:28:32 AM ET
    $ARTE
    Blank Checks
    Finance
    Get the next $ARTE alert in real time by email
    SC 13G/A 1 formsc13ga.htm FORM SC 13G/A Saba Capital Management, L.P.: Form SC 13G/A - Filed by newsfilecorp.com

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

    Artemis Strategic Investment Corporation

    (Name of Issuer)

    Common Stock, $0.0001 par value

    (Title of Class of Securities)

     

    04303A202

    (CUSIP Number)

     

    December 31, 2022

    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     [_]  Rule 13d-1(b)

     [X]  Rule 13d-1(c)

     [_]  Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    SCHEDULE 13G/A

    CUSIP No.           04303A202


    1 Names of Reporting Persons

    Saba Capital Management, L.P.
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    Delaware
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    978,818
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    978,818
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    978,818
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    4.9%
    12 Type of Reporting Person (See Instructions)

    PN; IA
           

    The percentages used herein are calculated based upon 20,125,000 shares of common stock outstanding as of October 31, 2022, as disclosed in the company's 10-Q filed November 9, 2022.

    Page 2 of 7


    SCHEDULE 13G/A

    CUSIP No.           04303A202


    1 Names of Reporting Persons

    Boaz R. Weinstein
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    United States
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    978,818
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    978,818
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    978,818
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    4.9%
    12 Type of Reporting Person (See Instructions)

    IN
           

    The percentages used herein are calculated based upon 20,125,000 shares of common stock outstanding as of October 31, 2022, as disclosed in the company's 10-Q filed November 9, 2022.

    Page 3 of 7


    CUSIP No.           04303A202


    1 Names of Reporting Persons

    Saba Capital Management GP, LLC
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    Delaware
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    978,818
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    978,818
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    978,818
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    4.9%
    12 Type of Reporting Person (See Instructions)

    OO
           

    The percentages used herein are calculated based upon 20,125,000 shares of common stock outstanding as of October 31, 2022, as disclosed in the company's 10-Q filed November 9, 2022.

    Page 4 of 7


    Item 1.

    (a) Name of Issuer: Artemis Strategic Investment Corporation

    (b) Address of Issuer's Principal Executive Offices: 3310 EAST CORONA AVENUE, PHOENIX, AZ, 85040

    Item 2.

    (a) Name of Person Filing: Saba Capital Management, L.P., a Delaware limited partnership ("Saba Capital"), Saba Capital Management GP, LLC, a Delaware limited liability company ("Saba GP"), and Mr. Boaz R. Weinstein (together, the "Reporting Persons").  The Reporting Persons have entered into a Joint Filing Agreement, dated October 8, 2021, pursuant to which the Reporting Persons have agreed to file this statement and any subsequent amendments hereto jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.  Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.  The filing of this statement should not be construed as an admission that any of the forgoing persons or the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the Common Stock reported herein.

    (b) Address of Principal Business Office or, if None, Residence:  The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174.

    (c) Citizenship: Saba Capital is organized as a limited partnership under the laws of the State of Delaware. Saba GP is organized as a limited liability company under the laws of the State of Delaware. Mr. Weinstein is a citizen of the United States.

    (d) Title and Class of Securities: Common stock, $0.0001 Par Value (the "Common Stock").

    (e) CUSIP No.: 04303A202

    Item 3.  If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    (a) [_] Broker or dealer registered under Section 15 of the Act;

    (b) [_] Bank as defined in Section 3(a)(6) of the Act;

    (c) [_] Insurance company as defined in Section 3(a)(19) of the Act;

    (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940;

    (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

    (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

    (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

    (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

    (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

    (j) [_] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

    Page 5 of 7


    (k) [_] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

    Item 4. Ownership

    (a) Amount Beneficially Owned:    The information required by Items 4(a) - (c) is set forth in Rows (5) - (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

    Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]

    Item 6. Ownership of more than Five Percent on Behalf of Another Person.  N/A

    Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. N/A

    Item 8. Identification and classification of members of the group. N/A

    Item 9. Notice of Dissolution of Group.  N/A

    Item 10. Certifications.

    By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    Page 6 of 7


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 14, 2023

    /s/ Signature  Michael D'Angelo

    Name: Michael D'Angelo

    Title: Chief Compliance Officer

    Boaz R. Weinstein

    By: Michael D'Angelo

    Title: Attorney-in-fact***

    *** Pursuant to a Power of Attorney dated as of November 16, 2015

    Page 7 of 7


    Get the next $ARTE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARTE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ARTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Artemis Strategic Investment Corporation files Form S-4 in Connection with Its Business Combination with Danam Health, Inc.

    PHOENIX, AZ / ACCESSWIRE / September 18, 2023 / Artemis Strategic Investment Corporation (NASDAQ:ARTE), a publicly traded special purpose acquisition company ("Artemis"), today announced the filing of its registration statement on Form S-4 (the "Registration Statement") with the United States Securities and Exchange Commission ("SEC") in connection with Artemis' business combination with Danam Health, Inc. ("Danam"), a health services technology and pharmaceutical distribution company pioneering a healthcare ecosystem model designed to bring efficiency to the prescription journey and promote medication compliance.The Registration Statement contains a preliminary proxy statement and prospectu

    9/18/23 6:00:00 PM ET
    $ARTE
    Blank Checks
    Finance

    Danam Health, Inc. and Artemis Strategic Investment Corporation Announce the Execution of a Definitive Merger Agreement

    Danam Health, Inc. ("Danam") is a health services technology and pharmaceutical distribution company pioneering an ecosystem model designed to empower various stakeholders in the prescription journey and patient medication compliance aspects of healthcare.Founded by a consortium of top-tier pharma executives dedicated to improving the last mile of medication and healthcare delivery, Danam aims to achieve commercial success by utilizing advanced integrative technology to overcome both cost- and geography-related patient access barriers.Danam leverages its proprietary technology to bridge the gap that exists among patients, practitioners, pharmacies, and pharmaceutical product accessibility by

    8/7/23 8:05:00 AM ET
    $ARTE
    Blank Checks
    Finance

    Artemis Strategic Investment Corporation Announces Contribution to Trust Account in Connection with Proposed Extension; Clarifies that Trust Account Will Not Be Decreased Due to Excise Tax

    Phoenix, Arizona--(Newsfile Corp. - June 20, 2023) - Artemis Strategic Investment Corporation (NASDAQ:ARTEU) (NASDAQ:ARTE) (NASDAQ:ARTEW) (the "Company") announced today that it had filed a supplement ("Proxy Supplement") to its definitive proxy statement dated June 9, 2023 ("Proxy Statement") for the solicitation of proxies in connection with a special meeting of the Company's stockholders scheduled to be held on June 29, 2023 (the "Extension Meeting"), to consider and vote on, among other proposals, a proposal to extend the date by which the Company must consummate a business combination.The Proxy Supplement discloses that, if the Company's stockholders approve the proposed amendment to th

    6/20/23 4:15:00 PM ET
    $ARTE
    Blank Checks
    Finance

    $ARTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider Atlas Merchant Capital Llc claimed ownership of 621,621 shares

    3 - Artemis Strategic Investment Corp (0001839990) (Issuer)

    7/27/23 4:15:37 PM ET
    $ARTE
    Blank Checks
    Finance

    $ARTE
    SEC Filings

    View All

    SEC Form 15-12G filed by Artemis Strategic Investment Corporation

    15-12G - Artemis Strategic Investment Corp (0001839990) (Filer)

    11/13/23 1:33:49 PM ET
    $ARTE
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Artemis Strategic Investment Corporation

    25-NSE - Artemis Strategic Investment Corp (0001839990) (Subject)

    11/3/23 4:17:54 PM ET
    $ARTE
    Blank Checks
    Finance

    Artemis Strategic Investment Corporation filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (Amendment)

    8-K/A - Artemis Strategic Investment Corp (0001839990) (Filer)

    11/2/23 5:00:14 PM ET
    $ARTE
    Blank Checks
    Finance

    $ARTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)

    2/14/24 4:55:24 PM ET
    $ARTE
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)

    2/14/24 4:47:18 PM ET
    $ARTE
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)

    2/9/24 11:59:40 AM ET
    $ARTE
    Blank Checks
    Finance